Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
2,060,454
-
Shares change
-
-575,294
-
Total reported value, excl. options
-
$84,527,079
-
Value change
-
-$23,583,901
-
Put/Call ratio
-
240%
-
Number of buys
-
21
-
Number of sells
-
-30
-
Price
-
$41.01
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q1 2023
77 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q1 2023.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,060,454 shares
.
Largest 10 shareholders include MORGAN STANLEY (583,072 shares), GOLDMAN SACHS GROUP INC (317,137 shares), BANK OF AMERICA CORP /DE/ (293,573 shares), LPL Financial LLC (95,426 shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (73,000 shares), WELLS FARGO & COMPANY/MN (49,303 shares), MAI Capital Management (48,969 shares), Royal Bank of Canada (48,275 shares), CITADEL ADVISORS LLC (46,118 shares), and FIRST CITIZENS BANK & TRUST CO (44,103 shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.